Skip to main content

Xtant Medical Holdings, Inc.

XTNT
Exchange
NYSE
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001453593

No open-market purchases or sales by Xtant Medical Holdings, Inc. insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $33.8M in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding Xtant Medical Holdings, Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of XTNT: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders1928+9
Shares81.8M90.3M+8.51M (+10.4%)
Value$76.0M$99.3M+$23.3M (+30.6%)

New holders (11)

Institutions that held Xtant Medical Holdings, Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to XTNT in Q3 2023
InstitutionSharesValue% of portfolio
Nantahala Capital Management, LLC4,000,000$4.40M0.56%
AMH Equity Ltd594,029$653.4K0.83%
AWM Investment Company, Inc.468,680$515.5K0.08%
Sterling Investment Advisors, Ltd.34,928$38.4K0.01%
Prudential Financial Inc18,800$20.7K0.00%
Goldman Sachs Group Inc12,923$14.2K0.00%
Susquehanna International Group, LLP12,727$14.0K0.00%
Citigroup Inc6,092$6.70K0.00%
UBS Group AG4,219$4.64K0.00%
JPMorgan Chase & Co32$350.00%
Cornerstone Planning Group LLC12$130.00%

Sold out (2)

Institutions that held Xtant Medical Holdings, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of XTNT in Q3 2023
InstitutionShares, Q2 2023Value, Q2 2023
Two Sigma Securities, LLC25,238$23.5K
Bank of America Corp106$98